1. The University of Texas System (28 from 5,450 patents)

2. Moleculin Biotech, Inc. (4 from 4 patents)

3. Other (3 from 832,843 patents)

4. Houston Pharmaceuticals, Inc. (2 from 3 patents)

5. The University of Mississippi (1 from 155 patents)

6. Moleculin, LLC (1 from 1 patent)

7. Charles Conrad (0 patent)

8. Jeffrey Myers (0 patent)

9. Waldemar Priebe (0 patent)

10. Slawomir Szymanski (0 patent)

11. Izabela Fokt (0 patent)

12. Nicholas Donato (0 patent)

13. Moshe Talpaz (0 patent)

14. Grynkiewicz, Grzegorz (0 patent)

15. Perez-soler, Roman (0 patent)

1. 12257262 - Method of reconstituting liposomal annamycin

2. 12257261 - Preparation of preliposomal Annamycin lyophilizate

3. 11980634 - Method of reconstituting liposomal annamycin

4. 11951118 - Preparation of preliposomal annamycin lyophilizate

5. 11925654 - Esters of 2-deoxy-monosaccharides with anti proliferative activity

6. 11026960 - Esters of 2-deoxy-monosaccharides with anti proliferative activity

7. 10703721 - Caffeic acid derivatives and uses thereof

8. 10358439 - DNA binding agents with a minor groove binding tail

9. 10201554 - Esters of 2-deoxy-monosacharides with anti proliferative activity

10. 9096499 - Compounds for treatment of cell proliferative diseases

11. 9000179 - Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)

12. 8927506 - Acetates of 2-deoxy monosaccharides with anticancer activity

13. 8779151 - Orally bioavailable caffeic acid related anticancer drugs

14. 8648102 - Compounds for treatment of cell proliferative diseases

15. 8637675 - Inhibitors of proliferation and activation of signal transducer and activators of transcription (STATS)